Abstract
Whole plant methanolic extracts of 14 traditionally used medicinal herbs were evaluated for their anti-inflammatory activity. Extracts of Grindelia robusta, Salix nigra, Arnica montana, and Quassia amara showed up to 4.5-fold inhibition of nitric oxide (NO) production in the J774 murine macrophage cells challenged with LPS without cytotoxicity. These four selected extracts significantly reduced the protein levels of inducible NO synthase (iNOS) and the cyclooxygenase-2 (COX-2) as observed by Western blot analysis. Culture supernatants from cells treated with these extracts indicated 3–5-fold reduction of tumor necrosis factor-α (TNF-α). However, only G. robusta and Q. amara extracts significantly inhibited (by 50%) IL-1β and IL-12 secretions. Furthermore, all these plant extracts were shown to prevent the LPS-mediated nuclear translocation of nuclear factor-κB (NF-κB). All the above observations indicate the anti-inflammatory potential of these plant extracts.
Similar content being viewed by others
References
Harvey AL (2008) Natural products in drug discovery. Drug Discov Today. doi:10.1016/j.drudis.2008.07.004
Chang J (2000) Medicinal herbs: drugs or dietary supplements? Biochem Pharmacol 59:211–219
Raghav SK, Gupta B, Shrivastava A, Das HR (2007) Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1β through suppression of NF-κB activation by 3-(1′-1′-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L. Eur J Pharmacol 560:69–80
Newman DJ, Cragg GM, Snader KM (2000) The influence of natural products upon drug discovery. Nat Prod Rep 17:215–234
Raskin I, Ripoll C (2004) Can an apple a day keep the doctor away? Curr Pharm Des 10:3419–3429
Mendelson R, Balick MJ (1995) The value of undiscovered pharmaceuticals in tropical forests. Econ Bot 49:223–228
Raskin I, Ribnicky DM, Komarnytsky S et al (2002) Plants and human health in the 21st century. Trends Biotechnol 20:522–531
Ohshima H, Bartsch H (1994) Chronic infections and inflammatory processes as cancer risk factors, possible role of nitric oxide in carcinogenesis. Mutat Res 305:253–264
Esposito K, Giugliano D (1994) The metabolic syndrome and inflammation, association or causation? Nutr Metab Cardiovasc Dis 14:228–232
Krakauer T (2004) Molecular therapeutic targets in inflammation, cyclooxygenase and NFκβ. Curr Drug Targets 3:317–324
Bonizzi G, Karin M (2004) The two NF-κB activation pathwaysand their role in innate and adaptive immunity. Trends Immunol 25:280–288
Duffield JS (2003) The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci 104:27–38
Nagatoshi F, Kazuo K (2005) Macrophages in inflammation. Curr Drug Targets 4:281–286
Juni P, Reichenbach S, Egger M (2005) COX2 inhibitors, traditional NSAIDs and the heart. Br Med J 330:1342–1343
Pathak SK, Sharma RA, Steward WP et al (2005) Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies. Eur J Cancer 41:61–70
Nathan C, Xie QW (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78:915–918
Li Q, Verma IM (2002) NF-κB regulation in the immune system. Nat Rev Immunol 2:725–734
Li Q, Withoff S, Verma IM (2005) Inflammation-associated cancer, NF-kappaB is the lynchpin. Trends Immunol 26:318–325
Lee DU, Kang YJ, Park MK et al (2003) Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-α, iNOS and IL-12 production in LPS stimulated macrophages. Life Sci 73:1401–1412
Schreiber E, Harshman K, Kemler I et al (1990) Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nucleic Acids Res 18:5495–5503
Kilbourn RG, Belloni P (1990) Endothelial cell production of nitric oxide in response to interferon-γ in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 82:772–776
Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051–3064
Murakami A, Takahashi D, Hagihara K et al (2003) Combinatorial effects of nonsteroidal anti-inflammatory drugs and food constituents on production of prostaglandin E2 and tumor necrosis factor alpha in RAW264.7 murine macrophages. Biosci Biotechnol Biochem 67:1056–1062
Zhang G, Ghosh S (2000) Molecular mechanisms of NF-κB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res 6:453–457
Albina JL, Reichner JS (1998) Role of nitric oxide mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev 17:39–53
Boucher JL, Moali C, Tenu JP (1999) Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for l-arginine utilization. Cell Mol Life Sci 55:1015–1028
Reddy ST, Herschman HR (1994) Ligand-induced prostaglandin synthase requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblast and macrophages. J Biol Chem 269:473–480
Lee SH, Soyoola E, Chanmugam P et al (1992) Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 267:934–938
Hughes FJ, Buttery LD, Hukkanen MV, O’Donnell A, Maclouf J, Polak JM (1999) Cytokine induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide dependent and independent mechanism in rat osteoblasts in vitro. J Biol Chem 274:1776–1782
Jachak SM (2006) Cyclooxygenase inhibitory natural products: current status. Curr Top Med Chem 13:659–678
Kim SJ, Jeong HJ, Moon PD (2005) Anti-inflammatory activity of gumiganghwaltang through the inhibition of nuclear factor-kappa B activation in peritoneal macrophages. Biol Pharm Bull 28:233–237
Anderson KV (2000) Toll signaling pathways in the innate immune response. Curr Opin Immunol 12:13–19
Ghosh S, May MJ, Kopp EB (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225–260
Baldwin AS (1996) The NF-κB and IκB proteins: new discoveries and insights. Ann Rev Immunol 14:649–683
Guha M, Mackman N (2001) LPS induction of gene expression in human monocytes. Cell Signal 13:85–94
Beutler B (2000) Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 12:20–26
Yang H, Young DW, Gusovsky F, Chow JC (2000) Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 275:20861–20866
Acknowledgments
Authors wish to thank the Council of Scientific and Industrial Research, India for the financial assistance.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Verma, N., Tripathi, S.K., Sahu, D. et al. Evaluation of inhibitory activities of plant extracts on production of LPS-stimulated pro-inflammatory mediators in J774 murine macrophages. Mol Cell Biochem 336, 127–135 (2010). https://doi.org/10.1007/s11010-009-0263-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-009-0263-6